Published in Steroids on August 08, 2009
An androgen receptor N-terminal domain antagonist for treating prostate cancer. J Clin Invest (2013) 1.64
Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation. Endocr Rev (2012) 1.11
Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr Relat Cancer (2010) 0.93
The dynamic structure of the estrogen receptor. J Amino Acids (2011) 0.92
Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis. J Thyroid Res (2011) 0.85
Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations. J Biol Chem (2012) 0.85
Structural diversity and evolution of the N-terminal isoform-specific region of ecdysone receptor-A and -B1 isoforms in insects. BMC Evol Biol (2010) 0.82
Transcription factor effector domains. Subcell Biochem (2011) 0.81
Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting. Asian J Androl (2016) 0.77
The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68
Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol (2005) 17.63
Gene regulation by steroid hormones. Cell (1989) 12.96
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35
Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet (1985) 10.62
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Nuclear receptors and lipid physiology: opening the X-files. Science (2001) 8.76
Intrinsic disorder and protein function. Biochemistry (2002) 8.54
Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (1986) 7.81
Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev (1999) 7.42
Natively unfolded proteins: a point where biology waits for physics. Protein Sci (2002) 6.91
Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol (2002) 6.53
Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc Natl Acad Sci U S A (2000) 5.71
Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J (2005) 5.36
Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev (1998) 5.28
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69
Natively unfolded proteins. Curr Opin Struct Biol (2005) 4.39
The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett (2005) 3.80
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit (2005) 3.57
Nuclear receptor coactivators and corepressors. Mol Endocrinol (1996) 3.44
Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature (2008) 3.44
Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell (2007) 3.18
Intrinsic disorder in transcription factors. Biochemistry (2006) 3.06
Nuclear receptor coactivators. Curr Opin Cell Biol (1997) 2.96
The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell (1993) 2.95
Atomic structure of progesterone complexed with its receptor. Nature (1998) 2.83
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J (1999) 2.81
Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem (1991) 2.79
FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol (2001) 2.76
Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A (1998) 2.68
Solution structure of the glucocorticoid receptor DNA-binding domain. Science (1990) 2.64
Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem (2000) 2.60
Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science (2003) 2.49
Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci U S A (2001) 2.38
Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J (1999) 2.24
Solution structure of the DNA-binding domain of the oestrogen receptor. Nature (1990) 2.13
Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A (2004) 1.97
Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem (1997) 1.92
Steroid hormone receptors: an update. Hum Reprod Update (2000) 1.90
The structure of the nuclear hormone receptors. Steroids (1999) 1.80
Human transcription factors contain a high fraction of intrinsically disordered regions essential for transcriptional regulation. J Mol Biol (2006) 1.71
The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol (1999) 1.70
The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem (2003) 1.61
Building transcriptional regulatory complexes: signals and surfaces. Cold Spring Harb Symp Quant Biol (1998) 1.52
A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol (1994) 1.48
Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27(Kip1). Biochemistry (2002) 1.43
Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem (2002) 1.41
Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol Endocrinol (2003) 1.38
Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J Mol Biol (2005) 1.36
Signal transduction via unstructured protein conduits. Nat Chem Biol (2008) 1.36
Trimethylamine N-oxide-induced cooperative folding of an intrinsically unfolded transcription-activating fragment of human glucocorticoid receptor. J Biol Chem (1999) 1.31
Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry (1996) 1.30
Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol Endocrinol (2003) 1.28
Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol (2001) 1.28
Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J (2005) 1.27
Unfolding the action of progesterone receptors. J Biol Chem (2003) 1.26
The evolution of the nuclear receptor superfamily. Essays Biochem (2004) 1.25
Interdomain signaling in a two-domain fragment of the human glucocorticoid receptor. J Biol Chem (1999) 1.24
Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc Natl Acad Sci U S A (1995) 1.23
Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol (1999) 1.23
The conformation of the glucocorticoid receptor af1/tau1 domain induced by osmolyte binds co-regulatory proteins. J Biol Chem (2001) 1.23
Conformational analysis of the androgen receptor amino-terminal domain involved in transactivation. Influence of structure-stabilizing solutes and protein-protein interactions. J Biol Chem (2002) 1.22
Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. Mol Endocrinol (1997) 1.22
Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci U S A (1995) 1.21
Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J Biol Chem (1996) 1.19
The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties. J Biol Chem (2001) 1.15
Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. Biochemistry (2004) 1.14
The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain. J Biol Chem (2000) 1.12
Antagonism in the human mineralocorticoid receptor. EMBO J (1998) 1.08
Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nucl Recept Signal (2007) 1.08
TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc Natl Acad Sci U S A (2004) 1.07
Structural disorder promotes assembly of protein complexes. BMC Struct Biol (2007) 1.07
Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors. Biochemistry (1998) 1.05
DNA recognition by nuclear receptors. Essays Biochem (2004) 1.04
Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Mol Endocrinol (1996) 1.01
Role of intrinsically disordered protein regions/domains in transcriptional regulation. Life Sci (2008) 1.01
A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation. Mol Endocrinol (2003) 1.01
Intrinsic disorder in yeast transcriptional regulatory network. Proteins (2007) 0.98
Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism. Mol Cell Biol (2005) 0.93
Activation function 1 of glucocorticoid receptor binds TATA-binding protein in vitro and in vivo. Mol Endocrinol (2006) 0.93
Function/activity of specific amino acids in glucocorticoid receptors. Vitam Horm (1994) 0.88
TIF2 mediates the synergy between RARalpha 1 activation functions AF-1 and AF-2. J Biol Chem (2002) 0.83
Effects of different osmolytes on the induced folding of the N-terminal activation domain (AF1) of the glucocorticoid receptor. Arch Biochem Biophys (2007) 0.83
Isoform-specific variation in the intrinsic disorder of troponin I. Proteins (2008) 0.81
Glucocorticoid receptor domain requirements for chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter in different nucleoprotein contexts. J Biol Chem (2002) 0.78
Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3. Cancer Res (2003) 1.02
Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival. J Immunol (2002) 0.96
Incretins and insulin secretion. Preface. Vitam Horm (2010) 0.85
Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain. J Biol Chem (2002) 0.83
TRAIL in the airways. Vitam Horm (2004) 0.83
Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res (2003) 0.82
Folic acid and folates. Preface. Vitam Horm (2008) 0.79
Modification of an essential amino group in the mineralocorticoid receptor evidences a differential conformational change of the receptor protein upon binding of antagonists, natural agonists and the synthetic agonist 11,19-oxidoprogesterone. Biochim Biophys Acta (2002) 0.78
Hormones of the limbic system. Preface. Vitam Horm (2010) 0.76
Evaluation of glucocorticoid sensitivity in 697 pre-B acute lymphoblastic leukemia cells after overexpression or silencing of MAP kinase phosphatase-1. J Cancer Res Clin Oncol (2005) 0.76
Pheromones. Preface. Vitam Horm (2010) 0.75
Hedgehog signaling. Preface. Vitam Horm (2012) 0.75
Preface. Insulin and IGFs. Vitam Horm (2009) 0.75
Sleep hormones. Preface. Vitam Horm (2012) 0.75
Activins and inhibins. Preface. Vitam Horm (2011) 0.75
Vitamin K. Preface. Vitam Horm (2008) 0.75
Anatomy of a new U.S. medical school: The Commonwealth Medical College. Acad Med (2010) 0.75
Vitamins and the immune system. Preface. Vitam Horm (2011) 0.75
Preface. Vitam Horm (2013) 0.75
Stem cell regulators. Preface. Vitam Horm (2011) 0.75
Adiponectin. Preface. Vitam Horm (2012) 0.75